Advanced Sequencing Applications For The Medical / Health Care Industry Available In California

Tesis Biosciences offers both an individual connective tissue panel and a comprehensive panel. Inherited connective tissue disorders are frequently caused by an aberration in a gene involved in the structure or function of connective tissue. If no pathogenic aberrations are detected by NGS, deletion/duplication analysis is performed to identify partial or whole gene deletions and duplications in the associated ...

By Tesis Biosciences based in Scottsdale, ARIZONA (USA).

Malignant Hyperthermia (MH) – A potentially lethal inherited disorder that can cause a severe reaction to certain anesthesia medicine. This condition can result in patients having hypoxemia, hypercapnia, tachycardia, muscular rigidity, acidosis, hyperkalemia, hyperthermia, and the overall inability to wake up after ...

By Tesis Biosciences based in Scottsdale, ARIZONA (USA).

Sample preparation is a significant yet underappreciated step that allows for high quality sequencing and analysis, critical to achieving breakthroughs in medicine, agriculture, and other industries. NanoCellect’s microfluidic cell sorter, the WOLF, allow the cell’s integrity to be maintained for numerous sequencing and multi-omics techniques. The WOLF’s ability to flexibly fit into any genomic researcher’s lab, make it a key step to any cell ...

By NanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA).

Data from examining the immune repertoire of cancer patients can be used to identify patterns associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single cell immune sequencing technologies provide an even more granular view of individual T cell or B cell populations following immunotherapy, providing unprecedented detail for informing cancer ...

By iRepertoire, Inc. based in Huntsville, ALABAMA (USA).

Cell-free DNA (cfDNA), found circulating in blood plasma, contains a wealth of clinically relevant biological information which can be recovered by minimally-invasive procedures. Next Generation Sequencing (NGS) data obtained from cfDNA, can be used to monitor prenatal health, organ transplant reception or rejection, cancer and other ...

By Claret Bioscience based in Santa Cruz, CALIFORNIA (USA).

The rapid emergence of the COVID-19 pandemic has thrust tools like next generation sequencing (NGS) applications to the forefront of the global public health response. ...

By AccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA).

Locus has built an automated, generalizable platform that is systematically unlocking the power of bacteriophage and CRISPR-Cas3 across multiple therapeutic ...

By Locus Biosciences, Inc. based in Morrisville, NORTH CAROLINA (USA).